AU7449000A - Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody - Google Patents

Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody

Info

Publication number
AU7449000A
AU7449000A AU74490/00A AU7449000A AU7449000A AU 7449000 A AU7449000 A AU 7449000A AU 74490/00 A AU74490/00 A AU 74490/00A AU 7449000 A AU7449000 A AU 7449000A AU 7449000 A AU7449000 A AU 7449000A
Authority
AU
Australia
Prior art keywords
antibody
derivative
human type
transplanted
determining domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74490/00A
Inventor
Nobuo Hanai
Kazuyasu Nakamura
Rinpei Niwa
Kenya Shitara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of AU7449000A publication Critical patent/AU7449000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3076—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
    • C07K16/3084—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties against tumour-associated gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU74490/00A 1999-09-30 2000-09-29 Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody Abandoned AU7449000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP27829099 1999-09-30
JP11/278290 1999-09-30
PCT/JP2000/006773 WO2001023573A1 (en) 1999-09-30 2000-09-29 Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody

Publications (1)

Publication Number Publication Date
AU7449000A true AU7449000A (en) 2001-04-30

Family

ID=17595301

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74490/00A Abandoned AU7449000A (en) 1999-09-30 2000-09-29 Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody

Country Status (2)

Country Link
AU (1) AU7449000A (en)
WO (1) WO2001023573A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1272205B1 (en) * 2000-03-07 2013-08-07 The Johns Hopkins University Sialoadhesin factor-2 antibodies
PT1572748E (en) * 2002-12-17 2010-09-28 Merck Patent Gmbh Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2
WO2005053742A1 (en) * 2003-12-04 2005-06-16 Kyowa Hakko Kogyo Co., Ltd. Medicine containing antibody composition
GB201403972D0 (en) * 2014-03-06 2014-04-23 Ucl Business Plc Chimeric antigen receptor
WO2024040195A1 (en) 2022-08-17 2024-02-22 Capstan Therapeutics, Inc. Conditioning for in vivo immune cell engineering

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034634A1 (en) * 1996-03-20 1997-09-25 Sloan-Kettering Institute For Cancer Research Single chain fv constructs of anti-ganglioside gd2 antibodies

Also Published As

Publication number Publication date
WO2001023573A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2001259215A1 (en) Human anti-cd40 antibodies and methods of making and using same
AU3030995A (en) Absorbent structure of sanitary article
AU4640400A (en) Analysis of differential protein expression
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU4670800A (en) Novel compositions comprising trimetrexate and methods of their synthesis and use
AU3068699A (en) Skin equivalent and methods of forming and using same
AU7100200A (en) Bleached grain and grain products and methods of preparation
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
AU7358800A (en) Compositions and methods for modification of skin lipid content
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU4848200A (en) Intravascular device and methods of manufacture and use
AU5269198A (en) Preparation of concealed taste preparations of antibacterially active quinolone derivatives
AU5674596A (en) Inhibitors of bacterial sialidase and methods of making and using the same
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU5759000A (en) Cold-plasma deposition treatment of seeds and other living matter
AU7449000A (en) Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody
AU1911301A (en) Novel bacterial isolate and the preparation and use of its active metabolites
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU3501700A (en) Human endokine alpha and methods of use
AU1812601A (en) Cover member and method of making same
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2738000A (en) Oral hygiene preparations; associated methods and kit
AU6777596A (en) Treatment of human prostate disease with beta-lapachone derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase